Pacira BioSciences, Inc. (PCRX) earnings date
Feb 25, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 37 days, typically, give or take 10 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q2 FY2026 | Tue, Aug 4, 2026 | after close | 35 | 8-K |
| Q1 FY2026 | Thu, Apr 30, 2026 | after close | 30 | 8-K |
| Q4 FY2025 | Thu, Feb 26, 2026 | after close | 57 | 8-K |
| Q3 FY2025 | Thu, Nov 6, 2025 | after close | 37 | 8-K |
| Q2 FY2025 | Tue, Aug 5, 2025 | after close | 36 | 8-K |
| Q1 FY2025 | Thu, May 8, 2025 | after close | 38 | 8-K |
| Q4 FY2024 | Thu, Feb 27, 2025 | after close | 58 | 8-K |
| Q3 FY2024 | Wed, Nov 6, 2024 | after close | 37 | 8-K |
What they guided beta
| Q2 FY2026 | "Enrollment in Part A concluded in June, with topline data expected by the end of 2026." exhibit |
| Q2 FY2026 | "See “Non-GAAP Financial Information” below. 2026 Financial Guidance Today the company is updating its full-year 2026 guidance to adjust for the recently completed divestiture of iovera° to Zimmer Biomet as follows:" exhibit |
| Q2 FY2026 | "The company is reiterating its remaining full-year 2026 guidance as follows:" exhibit |
| Q2 FY2026 | "Pacira management uses these measures to better analyze its financial results, estimate its future cost of goods sold, gross margin, R&D expense and SG&A expense outlook for 2026 and to help make managerial decisions." exhibit |
| Q1 FY2026 | "At March 31, 2026, the company had 39.3 million shares of common stock outstanding and $100.0 million remaining on its current share repurchase authorization, which expires December 31, 2026. 2026 Financial Guidance Today the company is reiterating its full-year 2026 guidance as follows:" exhibit |
| Q1 FY2026 | "Pacira management uses these measures to better analyze its financial results, estimate its future cost of goods sold, gross margin, R&D expense and SG&A expense outlook for 2026 and to help make managerial decisions." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/PCRX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/PCRX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/PCRX/"><img src="https://veritasdata.dev/embed/PCRX.svg" alt="PCRX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/PCRX/)
Script
<script async src="https://veritasdata.dev/embed/PCRX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/PCRX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.